When does Metsera report earnings and why does it matter for MTSR stock?

Metsera reports earnings on Mar 25 2026 after market close. The update matters because clinical progress, cash burn and guidance will likely move MTSR stock sharply in either direction.

What are the key financials investors should watch for MTSR stock?

Watch cash per share **$4.27**, operating cash flow metrics, R&D spending, and any guidance on runway. These items drive MTSR stock sentiment given the company’s clinical stage.

What is Meyka AI’s grade and what does it mean for MTSR stock?

Meyka AI rates MTSR **66.43 (B, HOLD)**. The grade reflects sector and benchmark comparisons, growth, metrics and forecasts. It is informational and not personalized advice.

What price targets and upside does the Meyka forecast show for MTSR stock?

Meyka AI projects a 1‑year price of **$148.30** (about **77.83%** upside from **$70.50**). The model also lists a 3‑year target near **$297.56**. Forecasts are projections, not guarantees.

US Stocks

Metsera (MTSR) NASDAQ $70.50 Mar 23 2026: Mar 25 earnings could reset valuation

ByDanny Kontos March 24, 2026March 24, 2026

Metsera, Inc. (MTSR) closed at $70.50 on NASDAQ in the United States on Mar 23 2026, ahead of its scheduled earnings release on Mar 25. MTSR stock has climbed sharply year-to-date, with a YTD gain of 166.04% and a 3‑month gain near 97.65%, making the upcoming report a likely volatility catalyst. Investors will watch guidance, cash runway and clinical updates for Metsera’s obesity and metabolic pipeline to gauge whether current valuation holds.